As of 2025-09-15, the Relative Valuation of Harmony Biosciences Holdings Inc (HRMY) is 56.32 USD. This relative valuation is based on P/E multiples. With the latest stock price at 32.39 USD, the upside of Harmony Biosciences Holdings Inc based on Relative Valuation is 73.9%.
The range of the Relative Valuation is 39.62 - 83.48 USD.
| Range | Selected | |
| Trailing P/E multiples | 12.6x - 24.0x | 15.8x |
| Forward P/E multiples | 18.9x - 30.4x | 23.0x |
| Fair Price | 39.62 - 83.48 | 56.32 |
| Upside | 22.3% - 157.7% | 73.9% |
| Date | P/E |
| 2025-09-12 | 10.30 |
| 2025-09-11 | 10.63 |
| 2025-09-10 | 10.56 |
| 2025-09-09 | 10.81 |
| 2025-09-08 | 11.39 |
| 2025-09-05 | 11.45 |
| 2025-09-04 | 11.54 |
| 2025-09-03 | 11.94 |
| 2025-09-02 | 11.80 |
| 2025-08-29 | 11.73 |
| 2025-08-28 | 12.07 |
| 2025-08-27 | 12.10 |
| 2025-08-26 | 11.82 |
| 2025-08-25 | 11.90 |
| 2025-08-22 | 12.04 |
| 2025-08-21 | 11.86 |
| 2025-08-20 | 11.65 |
| 2025-08-19 | 11.58 |
| 2025-08-18 | 11.58 |
| 2025-08-15 | 11.73 |
| 2025-08-14 | 11.61 |
| 2025-08-13 | 11.66 |
| 2025-08-12 | 11.28 |
| 2025-08-11 | 11.07 |
| 2025-08-08 | 10.87 |
| 2025-08-07 | 10.87 |
| 2025-08-06 | 11.03 |
| 2025-08-05 | 11.11 |
| 2025-08-04 | 11.30 |
| 2025-08-01 | 10.94 |
| 2025-07-31 | 11.19 |
| 2025-07-30 | 11.28 |
| 2025-07-29 | 11.27 |
| 2025-07-28 | 11.37 |
| 2025-07-25 | 11.93 |
| 2025-07-24 | 11.67 |
| 2025-07-23 | 11.84 |
| 2025-07-22 | 11.67 |
| 2025-07-21 | 11.21 |
| 2025-07-18 | 11.19 |
| 2025-07-17 | 11.59 |
| 2025-07-16 | 11.20 |
| 2025-07-15 | 11.08 |
| 2025-07-14 | 11.04 |
| 2025-07-11 | 10.81 |
| 2025-07-10 | 10.92 |
| 2025-07-09 | 10.90 |
| 2025-07-08 | 10.41 |
| 2025-07-07 | 10.25 |
| 2025-07-03 | 10.23 |